GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daito Pharmaceutical Co Ltd (TSE:4577) » Definitions » Retained Earnings

Daito Pharmaceutical Co (TSE:4577) Retained Earnings : 円36,131 Mil (As of Feb. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Daito Pharmaceutical Co Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Daito Pharmaceutical Co's retained earnings for the quarter that ended in Feb. 2024 was 円36,131 Mil.

Daito Pharmaceutical Co's quarterly retained earnings increased from Aug. 2023 (円35,257 Mil) to Nov. 2023 (円36,126 Mil) and increased from Nov. 2023 (円36,126 Mil) to Feb. 2024 (円36,131 Mil).

Daito Pharmaceutical Co's annual retained earnings increased from May. 2021 (円28,331 Mil) to May. 2022 (円32,338 Mil) and increased from May. 2022 (円32,338 Mil) to May. 2023 (円35,006 Mil).


Daito Pharmaceutical Co Retained Earnings Historical Data

The historical data trend for Daito Pharmaceutical Co's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daito Pharmaceutical Co Retained Earnings Chart

Daito Pharmaceutical Co Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21,301.63 24,742.93 28,331.00 32,338.00 35,006.00

Daito Pharmaceutical Co Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34,066.00 35,006.00 35,257.00 36,126.00 36,131.00

Daito Pharmaceutical Co Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


Daito Pharmaceutical Co  (TSE:4577) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Daito Pharmaceutical Co (TSE:4577) Business Description

Traded in Other Exchanges
N/A
Address
326 Yokamachi, Toyama, JPN, 939-8567
Daito Pharmaceutical Co Ltd is engaged in the research and development of pharmaceutical products. The company also undertakes contract manufacturing.

Daito Pharmaceutical Co (TSE:4577) Headlines

No Headlines